IL6 and polycystic ovary syndrome: Our results demonstrating significantly elevated IL-6 levels in PCOS patients exhibiting insulin resistance complement the narrative established by Peng et al., which emphasized IL-6 as a critical mediator of inflammation in PCOS and delineated its correlation with the severity of insulin resistance and clinical manifestations [16].